XML 36 R67.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share-Based Compensation (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
12 Months Ended 0 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2012
Restricted Stock [Member]
Dec. 31, 2011
Restricted Stock [Member]
Dec. 31, 2010
Restricted Stock [Member]
Dec. 31, 2012
Stock Options [Member]
Dec. 31, 2011
Stock Options [Member]
Dec. 31, 2010
Stock Options [Member]
Jan. 02, 2013
Stock Award [Member]
Feb. 07, 2013
Stock Award [Member]
Restricted Stock [Member]
Feb. 07, 2013
Restricted Stock [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]                        
Share-based compensation incurred $ 10,371 $ 8,247 $ 6,487 $ 9,846 $ 7,308 $ 5,232 $ 525 $ 939 $ 1,255      
Capitalized share-based compensation (908) (663) (745)                  
Share-based compensation expense 9,463 7,584 5,742                  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]                        
Volatility     30.00%                  
Expected dividend yield     4.00%                  
Expected term (in years)     4 years 4 months                  
Risk free interest rate     1.90%                  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]                        
Outstanding at the beginning of year (in shares) 517,653                      
Outstanding at the beginning of year, Weighted-Average Exercise Price (in dollars per share) $ 61.08                      
Granted (in shares) 0 0                    
Granted, Weighted-Average Exercise Price (in dollars per share) $ 0.00                      
Exercised (in shares) (97,430)                      
Exercised, Weighted-Average Exercise Price (in dollars per share) $ 58.46                      
Forfeited or expired (in shares) (29,334)                      
Forfeited or Expired, Weighted-Average Exercise Price (in dollars per share) $ 44.61                      
Outstanding at the end of year (in shares) 390,889 517,653                    
Outstanding at the end of year, Weighted-Average Exercise Price (in dollars per share) $ 62.96 $ 61.08                    
Outstanding at the end of year, Intrinsic Value 16,048                      
Exercisable at the end of year (in shares) 293,946                      
Exercisable, Weighted-Average Exercise Price (in dollars per share) $ 65.66                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 5 years 2 months                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term 5 years                      
Exercisable, Aggregate Intrinsic Value $ 11,276                      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]                        
Unvested at the beginning of year (in shares) 282,837                      
Unvested at the beginning of year, Weighted-Average Grant-Date Fair Value (in dollars per share) $ 74.00                      
Granted (in shares) 126,169                 5,767 98,913  
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period                       3 years
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value $ 96.35 $ 81.94 $ 73.51                  
Vested (in shares) (106,804)                      
Vested, Weighted-Average Grant-Date Fair Value (in dollars per share) $ 72.78                      
Forfeited (in shares) (14,522)                      
Forfeited, Weighted-Average Grant-Date Fair Value (in dollars per share) $ 53.76                      
Unvested at the end of year (in shares) 287,680 282,837                    
Unvested at the end of year, Weighted-Average Grant-Date Fair Value (in dollars per share) $ 85.28 $ 74.00